Connor, Clark & Lunn Investment Management (CC&L)’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-52,990	Closed	-$1.43M	–	1697
2024 Q2	$1.43M	Buy	52,990 +16,231	+44%	+$338K	0.01%	763
2024 Q1	$673K	Buy	+36,759	New	+$583K	﹤0.01%	1020

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s SILK Position: Q3 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 52,990 shares — an estimated $1.43M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in SILK in Q1 2024 and held it in 2 quarters. The position peaked at $1.43M in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 52,990 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $1.43M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Silk Road Medical, Inc. Common Stock position peaked at $1.43M in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2024, filed 8 Nov 2024.